Serotonin modulates lineage plasticity in neuroendocrine prostate cancer via epigenetic reprogramming.

Neuroendocrine prostate cancer (NEPC) is an aggressive, therapy-resistant subtype of prostate cancer characterized by lineage plasticity. While metabolic and signaling molecules are increasingly recognized as modulators of tumor progression, their ro…

Preview only. Read the full abstract at the source